The October 2008 edition of ‘Drug Safety Update’ from the MHRA has issued guidance following information from the Serious Organised Crime Agency of a methylamphetamine
lab and 100 empty packs of single-constituent pseudoephedrine that were recently found in the London area.

The MHRA note that pseudoephedrine and ephedrine must be sold in line with the recent change and recommend the following advice for pharmacists:
• Please brief your healthcare team on this recent incident of illicit use
• Ensure all requests for more than one pack of a product that contains pseudoephedrine or ephedrine are referred to a pharmacist
• Report any suspicious activity in line with guidance from the Royal Pharmaceutical Society of Great Britain